equal-weight valid
bull bear point
remain equal-weight given concern organ
sale growth deceler price dissip worri
forward promot could pick and/or pulp cost could
rebound also see ep guidanc visibl
high assum reinvest valuat reason
valid bull bear argument leav us one
stock see bull bear argument reason
leav us middl equal-weight rate see bull
argument visibl look high reinvest ad spend bp
sale assum reinvest alreadi lower
pulp cost valuat look reason howev also see valid
bear argument promot like pick go forward see
risk rebound spot pulp price impress solid
organ sale growth result would note share gain
acceler recent reinvest stock would look compel
us worri top-line growth slow price moder
seemingli support vs mse fiscal organ sale
growth guidanc manag expect support innov
ration competit environ unsurprisingli market seem share
mix view around guidanc roughli
line gener solid perform slight ep beat
top-line upsid gm favor reinvest ad spend ultim
overshadow unsurpris initi guidanc ep guidanc
bracket consensu mse
number ep came slightli ahead
consensu mse in-lin profit margin upsid equiti
incom net view quarter solid top-line beat consensu
bp organ sale round vs consensu mse driven
sustain price/mix price mix volum reflect
acceler averag trend vs meanwhil
strong gross margin beat bp ahead consensu input cost
tailwind higher expect cost save reinvest compani
mr sg rise bp yoy vs bp come ahead
household person unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
consensu drive in-lin profit perform oper profit
consensu profit line higher expect equiti incom
ad cent upsid mse ep indic advertis
spend increas yoy bp sale full-year
repurchas share share outstand averag
price
top-line detail report solid yoy organ top-line growth
comparison year ago yoy growth deceler vs
yr averag sequenti acceler high level
price continu drive growth across region slight benefit
mix volum declin manag expect
contribut volum expect balanc growth
volum mix littl price remain optimist industri
price environ remain ration see downsid risk
volum growth fulli recov given inelast categori
organ sale target fall slightli guidanc
north america consum product organ sale grew mute scanner
trend quarter albeit sequenti acceler slightli vs
continu support outsiz contribut untrack channel
us growth support innov adult incontin categori
sale grew yoy ex-argentina strong growth eastern europ
organ sale brazil hsd china hsd off-set weaker result
latam countri notabl peru bolivia chile
margin detail report anoth quarter build input cost tailwind
mln tailwind vs mln consecut prior quarter
input cost headwind guid mln total tailwind
said manag indic expect input cost sequenti rise
back half given industri forecast pulp price inflat
combin increasingli favor input cost environ price benefit
cost save result bp yoy gm expans partial
reinvest advertising/market oper margin expand modest
bp yoy manag guid yoy oper profit
growth detail profit build support growth high end
rang roughli line consensu provid degre
visibl ep view
segment result segment person organ sale vs
consensu mse consum tissu vs
consensu mse kc-profession vs
consensu mse region basi person organ sale
north america price mix volum develop
emerg market price mix volum develop
market ex-north america consum tissu organ sale round
north america price volum flat develop emerg market
price volum develop market ex-north america
in-lin initi guidanc ep guidanc
bracket consensu mse impli fy ep growth
essenti in-lin indic call expect
ep growth in-lin lt target msd expect
organ sale growth mse driven higher net sell price volum
product mix report net sale growth limit fx
top-line headwind slight divestitur impact also expect
adjust oper profit growth vs consensu alreadi high end
rang cost input expect declin driven
pulp expect increas advertis spend anticip cost
save includ program
global restructur program fx translat
transact effect expect unfavor interest rate expect
increas somewhat yoy expect tax rate vs
net incom equiti compani expect higher yoy anticip
capit spend includ signific spend relat
global restructur program also implement dividend increas
approv board expect share repurchas
vs
remain equal-weight rais pt previous due
slightli higher ep top-lin gross margin
out-performance remain ew valuat reason price-to-earnings
discount larg cap hpc peer
need better visibl move toward attract bull case return
need better visibl move toward attract bull case return
project long-term organ revenu growth
in-lin medium term
guidanc lower past
driven mute categori growth
declin birth rate us/develop
market soft share trend
ep guidanc achiev post
solid result detail profit
build point ep high-end
pg/cl/chd/clx appropri consid
lower long-term organ sale
growth/ep outlook lower gm
commod sensit margin profil
risk achiev price
upsid risk includ lower expect
share trend greater price realiz
downsid risk includ greater
price realiz cost-cut downsid
pt reflect base case assumpt
price pass-through weaker-than-expect commod drive margin
upsid innovation/trad privat label drive volum upsid
bp price off-set commod lower fear bp
volum upsid trade up/new product usd weaken valuat
expand ep standard deviat last average
modest top-line deceler organ sale growth deceler
vs oper margin expand bp
driven commod cost fx cost save price benefit
valuat ep histor averag ntm price-to-earnings
price strong expect pg/pl pressur volum share
loss input cost ramp competit pressur increas drive
price bp volum bp forecast commod cost add
bp oper margin downsid usd strengthen valuat contract
ep slightli last average
exhibit bear bull price commod cut driver
valu
product sold
sale
sale bp chang
sale
sale bp chang
incom equiti interest
net incom equiti compani
net incom non-controlling interest
cash equival
invest equiti compani
redeem prefer common secur sub
depreci amort
increas decreas oper work capit
net loss asset disposit
equiti compani earn excess dividend
provid oper
acquisit busi net
proce sale invest
proce disposit properti
net chang time deposit
use invest
net increas decreas short-term debt
net increas decreas long-term debt
proce exercis stock option
purchas treasuri share
use financ
provid discontinu oper
effect exchang rate
net increas decreas
equiv beg
equiv end
